China SXT Pharmaceuticals annual current ratio
2018
2019
2020
2021
2022
2023
2024
2025
2026
China SXT Pharmaceuticals Current Ratio Growth & History (SXTC)
China SXT Pharmaceuticals's current ratio was 7.93 for fiscal 2026.
View full China SXT Pharmaceuticals company overviewChina SXT Pharmaceuticals annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | 7.93 | 4.39 | +123.99% |
| 2025 | 2025-03-31 | 3.54 | 1.94 | +121.55% |
| 2024 | 2024-03-31 | 1.60 | 0.25 | +18.74% |
| 2023 | 2023-03-31 | 1.35 | 0.04 | +2.69% |
| 2022 | 2022-03-31 | 1.31 | 0.06 | +4.87% |
| 2021 | 2021-03-31 | 1.25 | −0.35 | −21.90% |
| 2020 | 2020-03-31 | 1.60 | −0.86 | −35.07% |
| 2019 | 2019-03-31 | 2.47 | 1.07 | +76.68% |
| 2018 | 2018-03-31 | 1.40 | — | — |
China SXT Pharmaceuticals quarterly current ratio
Q4.18
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q2.22
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
Q2.26
Q4.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-03-31 | 7.93 | 4.39 | +123.99% |
| Q2 2026 | 2025-09-30 | 4.37 | 2.96 | +211.21% |
| Q4 2025 | 2025-03-31 | 3.54 | 1.94 | +121.55% |
| Q2 2025 | 2024-09-30 | 1.40 | −0.06 | −4.30% |
| Q4 2024 | 2024-03-31 | 1.60 | 0.25 | +18.74% |
| Q2 2024 | 2023-09-30 | 1.47 | −0.23 | −13.46% |
| Q4 2023 | 2023-03-31 | 1.35 | 0.04 | +2.69% |
| Q2 2023 | 2022-09-30 | 1.70 | 0.38 | +29.06% |
| Q4 2022 | 2022-03-31 | 1.31 | 0.06 | +4.87% |
| Q2 2022 | 2021-09-30 | 1.31 | −2.69 | −67.21% |
| Q4 2021 | 2021-03-31 | 1.25 | −0.35 | −21.90% |
| Q2 2021 | 2020-09-30 | 4.01 | 2.38 | +145.80% |
| Q4 2020 | 2020-03-31 | 1.60 | −0.86 | −35.07% |
| Q2 2020 | 2019-09-30 | 1.63 | — | — |
| Q4 2019 | 2019-03-31 | 2.47 | 1.07 | +76.68% |
| Q4 2018 | 2018-03-31 | 1.40 | — | — |
China SXT Pharmaceuticals current ratio trends
Over the last five fiscal years, China SXT Pharmaceuticals's current ratio increased from 1.25 to 7.93, a change of 6.68. The latest reported quarter, Q4 2026, shows 7.93.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review China SXT Pharmaceuticals source filings ↗